ArTara Therapeutics, Inc.
1 Little West 12th Street
New York, NY 10014
(646) 844-0337
February 6, 2020
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: William Mastrianna
Re: ArTara Therapeutics, Inc.
Registration Statement on Form S-3
File No. 333-236173
Acceleration Request
|
Requested Date: |
Monday, February 10, 2020 |
|
Requested Time: |
4:30 p.m. Eastern Time |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, ArTara Therapeutics, Inc. hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective at 4:30 p.m. Eastern Time on Monday, February 10, 2020, or as soon thereafter as is practicable.
Once the Registration Statement has been declared effective, please orally confirm that event with Ryan S. Sansom of Cooley LLP at (617) 937-2335 or Karen E. Deschaine of Cooley LLP at (858) 550-6088.
Sincerely,
ARTARA THERAPEUTICS, INC.
|
By: |
/s/ Jesse Shefferman |
|
|
|
Jesse Shefferman |
|
|
|
President and Chief Executive Officer |
|